CrAssphage

From WikiMD's Medical Encyclopedia

CrAssphage Virion

CrAssphage

CrAssphage
Illustration of CrAssphage

CrAssphage is a type of bacteriophage that was discovered in 2014. It is a virus that infects bacteria in the human gut, specifically targeting Bacteroides species. The name "CrAssphage" stands for "cross-assembly phage," reflecting its unique genetic makeup.

Discovery[edit]

CrAssphage was first identified through metagenomic analysis of human fecal samples. Researchers found that it is one of the most abundant viruses present in the human gut microbiome. Despite its prevalence, relatively little is known about its specific interactions with host bacteria and the impact it may have on human health.

Structure and Genome[edit]

The genome of CrAssphage is approximately 97,000 base pairs long and contains genes that code for various proteins involved in viral replication and assembly. Its structure is typical of a bacteriophage, with a head containing the genetic material and a tail used for attaching to and infecting bacterial cells.

Role in the Gut Microbiome[edit]

Studies have suggested that CrAssphage may play a role in shaping the composition of the gut microbiome by influencing the abundance of Bacteroides species. These bacteria are important for maintaining gut health and performing various metabolic functions.

Future Research[edit]

Further research is needed to understand the full extent of CrAssphage's impact on the gut microbiome and human health. Investigating its interactions with host bacteria and potential therapeutic applications could provide valuable insights into the complex dynamics of the gut ecosystem.


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.